Snowden Capital Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-733
| Closed | -$7.44K | – | 1243 |
|
|
2024
Q4 | $7.44K | Hold |
733
| – | – | ﹤0.01% | 1188 |
|
|
2024
Q3 | $9.13K | Hold |
733
| – | – | ﹤0.01% | 1212 |
|
|
2024
Q2 | $9.54K | Hold |
733
| – | – | ﹤0.01% | 1182 |
|
|
2024
Q1 | $16.6K | Hold |
733
| – | – | ﹤0.01% | 1165 |
|
|
2023
Q4 | $9.52K | Buy |
+733
| New | +$9.52K | ﹤0.01% | 1110 |
|
|
2023
Q3 | – | Sell |
-1,080
| Closed | -$29K | – | 1128 |
|
|
2023
Q2 | $29K | Hold |
1,080
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q1 | $63K | Buy |
1,080
+131
| +14% | +$7.64K | ﹤0.01% | 1124 |
|
|
2022
Q4 | $48.4K | Buy |
949
+136
| +17% | +$6.94K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $66K | Hold |
813
| – | – | ﹤0.01% | 1084 |
|
|
2022
Q2 | $55K | Sell |
813
-7
| -0.9% | -$474 | ﹤0.01% | 1094 |
|
|
2022
Q1 | $90K | Buy |
820
+547
| +200% | +$60K | ﹤0.01% | 999 |
|
|
2021
Q4 | $26K | Buy |
+273
| New | +$26K | ﹤0.01% | 1237 |
|